United States
Germany
Japan
United Kingdom
China
NKX3.1 mouse monoclonal antibody, clone OTI6E7 (formerly 6E7)
| Applications | IHC, WB |
| Reactivities | Human |
Antibodies
NKX3.1 mouse monoclonal antibody, clone OTI2D11 (formerly 2D11)
| Applications | IHC, WB |
| Reactivities | Human |
NKX3.1 mouse monoclonal antibody, clone OTI2A5 (formerly 2A5)
| Applications | IHC, WB |
| Reactivities | Human |
NKX3.1 mouse monoclonal antibody, clone OTI4H6 (formerly 4H6)
| Applications | IHC, WB |
| Reactivities | Human |
NKX3.1 mouse monoclonal antibody, clone OTI9H7 (formerly 9H7)
| Applications | IHC, WB |
| Reactivities | Human |
NKX3.1 mouse monoclonal antibody, clone OTI1C2 (formerly 1C2)
| Applications | IHC, WB |
| Reactivities | Human |
NKX3.1 mouse monoclonal antibody, clone OTI4B4 (formerly 4B4)
| Applications | IHC, WB |
| Reactivities | Human |
NKX3.1 mouse monoclonal antibody, clone OTI1B9 (formerly 1B9)
| Applications | IHC, WB |
| Reactivities | Human |
NKX3.1 mouse monoclonal antibody, clone OTI6D1 (formerly 6D1)
| Applications | IHC, WB |
| Reactivities | Human |
NKX3.1 mouse monoclonal antibody, clone OTI2D2 (formerly 2D2)
| Applications | IHC, WB |
| Reactivities | Human |
NKX3.1 mouse monoclonal antibody, clone OTI1B4 (formerly 1B4)
| Applications | IHC, WB |
| Reactivities | Human |
NKX3.1 mouse monoclonal antibody, clone OTI3H7 (formerly 3H7)
| Applications | IHC |
| Reactivities | Human |
NKX3.1 mouse monoclonal antibody, clone OTI2E4 (formerly 2E4)
| Applications | IHC |
| Reactivities | Human |
NKX3.1 mouse monoclonal antibody, clone OTI2D11 (formerly 2D11)
| Applications | IHC, WB |
| Reactivities | Human |
NKX3.1 mouse monoclonal antibody, clone OTI4B4 (formerly 4B4)
| Applications | IHC, WB |
| Reactivities | Human |
